Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Fragile X syndrome, caused by the loss of Fmr1 gene function, is the most common form of inherited mental retardation, with no effective treatment. Using a tractable animal model, we investigated mechanisms of action of a few FDA-approved psychoactive drugs that modestly benefit the cognitive performance in fragile X patients. Here we report that compounds activating serotonin (5HT) subtype 2B receptors (5HT 2B-Rs) or dopamine (DA) subtype 1-like receptors (D 1-Rs) and/or those inhibiting 5HT 2A-Rs or D 2-Rs moderately enhance Ras–PI3K/PKB signaling input, GluA1-dependent synaptic plasticity, and learning in Fmr1 knockout mice. Unexpectedly, combinations of these 5HT and DA compounds at low doses synergistically stimulate Ras–PI3K/PKB signal transduction and GluA1-dependent synaptic plasticity and remarkably restore normal learning in Fmr1 knockout mice without causing anxiety-related side effects. These findings suggest that properly dosed and combined FDA-approved psychoactive drugs may effectively treat the cognitive impairment associated with fragile X syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 2×
“Because developing a new drug takes ;8– 15 years (>13 years for neurological disorders) and costs ;$800 million–$1800 million (Adams and Brantner 2010; Paul et al. 2010), any effective treatment for fragile X 2014 Lim et al. This article is distributed exclusively by Cold Spring Harbor Laboratory…”
BackgroundFMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 1×
“This synergistic effect can take place within 1 d after application or administration of the 5HTand DA compounds, which rules out the contribution from the indirect effects of 5HT and DA compounds (e.g., changes in mood/anxiety) that take $2 wk to develop (Wong and Licinio 2001; David et al. 2010).”
BackgroundHayashi, Y., Shi, S.-H., Esteban, J. A., Piccini, A., Poncer, J.-C., & Malinow, R. (2000) · Science · doi:10.1126/science.287.5461.2262 · Cited by 1,524 · cited 1×
“We monitored the GluA1dependent plasticity by expressing the GFP-tagged GluA1 (GluA1-GFP), which is an ‘‘electrophysiologically tagged’’ or rectified channel (Hayashi et al. 2000), in CA1 neurons of wild-type and Fmr1 knockout mice.”
MethodRoth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Synaptic AMPA receptor plasticity and behavior
Kessels, H. W., & Malinow, R. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.015 · Cited by 993 · cited 1×
“Spontaneous synaptic activity in cultured slices does not drive GluA1containing AMPA-Rs into synapses but does so in the presence of histamine (Qin et al. 2005; McCormack et al. 2006; Kessels and Malinow 2009); thus, histamine was included in all in vitro trafficking experiments.”
BackgroundVyazovskiy, V. V., Cirelli, C., Pfister-Genskow, M., Faraguna, U., & Tononi, G. (2008) · Nature Neuroscience · doi:10.1038/nn2035 · Cited by 837 · cited 1×
“…in saline, and saline alone was tested as controls, and their dosages were estimated based on the published data (PuglisiAllegra and Cabib 1988; Costall and Naylor 1995; Kennett et al. 1997; O’Dell et al. 2000; Usiello et al. 2000; Wang et al. 2008) and dose response curves (cf. Supplemental Fig.”
MethodImportance of AMPA Receptors for Hippocampal Synaptic Plasticity But Not for Spatial Learning
Zamanillo, D., Sprengel, R., Hvalby, Ø., Jensen, V., Burnashev, N., Rozov, A., Kaiser, K. M. M., Köster, H. J., Borchardt, T., Worley, P., et al. (1999) · Science · doi:10.1126/science.284.5421.1805 · Cited by 791 · cited 2×
“…exhibit a selective impairment in associative learning (Maes et al. 1994; Paradee et al. 1999; Van Dam et al. 2000; Frankland et al. 2004; Zhao et al. 2005; Hayashi et al. 2007; Lanfranchi et al. 2009), an exact phenocopy of GluA1 knockout mice (Zamanillo et al. 1999; Schmitt et al. 2004, 2005).”
BackgroundDistinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676 · cited 2×
“…exhibit a selective impairment in associative learning (Maes et al. 1994; Paradee et al. 1999; Van Dam et al. 2000; Frankland et al. 2004; Zhao et al. 2005; Hayashi et al. 2007; Lanfranchi et al. 2009), an exact phenocopy of GluA1 knockout mice (Zamanillo et al. 1999; Schmitt et al. 2004, 2005).”
BackgroundResearch and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty
Li, S., Cullen, W. K., Anwyl, R., & Rowan, M. J. (2003) · Nature Neuroscience · doi:10.1038/nn1049 · Cited by 568 · cited 1×
“In particular, D1-Rs enhance LTP and/or inhibit depotentiation (Otmakhova and Lisman 1998; Gurden et al. 2000; Li et al. 2003; Chen et al. 2004), whereas D2-Rs inhibit LTP and/or enhance depotentiation (Li et al. 2007; Kwon et al. 2008).”
BackgroundDysregulation of mTOR signaling in fragile X syndrome
Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557
Emotion Enhances Learning via Norepinephrine Regulation of AMPA-Receptor Trafficking
Hu, H., Real, E., Takamiya, K., Kang, M.-G., Ledoux, J., Huganir, R. L., & Malinow, R. (2007) · Cell · doi:10.1016/j.cell.2007.09.017 · Cited by 496 · cited 1×
“…rescue is consistent with the findings that Fmr1 knockout mice have a predominant deficit in GluA1-dependent synaptic plasticity (Hu et al. 2008; Soden and Chen 2010), and synaptic GluA1 delivery is required for associative learning (Rumpel et al. 2005; Hu et al. 2007; Matsuo et al. 2008).”
ResultThe translation of translational control by FMRP: therapeutic targets for FXS
Darnell, J. C., & Klann, E. (2013) · Nature Neuroscience · doi:10.1038/nn.3379 · Cited by 491 · cited 5×
“Fragile X syndrome, the most common form of inherited mental impairment, is caused by the loss of function of the fragile X mental retardation protein (FMRP), coded by gene Fmr1 (Bagni and Greenough 2005; Levenga et al. 2010).”
BackgroundInfluentialFrom mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome
Bagni, C., & Greenough, W. T. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1667 · Cited by 475
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Bhakar, A. L., Dölen, G., & Bear, M. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153138 · Cited by 370
The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity
Li, B., Woo, R.-S., Mei, L., & Malinow, R. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.028 · Cited by 354
The organization of two new cortical interneuronal circuits
Jiang, X., Wang, G., Lee, A. J., Stornetta, R. L., & Zhu, J. J. (2013) · Nature Neuroscience · doi:10.1038/nn.3305 · Cited by 338
Self-citationParadee, W., Melikian, H. E., Rasmussen, D. L., Kenneson, A., Conn, P. J., & Warren, S. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00285-7 · Cited by 305 · cited 6×
“Consistent with clinical observations, Fmr1 knockout mice, an animal model for fragile X syndrome (The Dutch-Belgian Fragile X Consortium 1994), exhibit impaired associative learning but show no defects in spatial learning (Paradee et al. 1999; Van Dam et al. 2000; Zhao et al. 2005; Hayashi et al. 2007; Guo et al. 201…”
BackgroundResultInfluentialTrace but not delay fear conditioning requires attention and the anterior cingulate cortex
Han, C. J., O'Tuathaigh, C. M., van Trigt, L., Quinn, J. J., Fanselow, M. S., Mongeau, R., Koch, C., & Anderson, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2132313100 · Cited by 302 · cited 2×
“7A), the trace fear conditioning paradigm, which is sensitive to attention-distracting stimuli (Han et al. 2003) and severely impaired in Fmr1 knockout mice (Zhao et al. 2005; Hayashi et al. 2007; Guo et al. 2011).”
BackgroundDeficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome
Zhao, M.-G., Toyoda, H., Ko, S. W., Ding, H.-K., Wu, L.-J., & Zhuo, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1520-05.2005 · Cited by 296
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Peier, A. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1145 · Cited by 285
Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice
Hayashi, M. L., Rao, B. S. S., Seo, J.-S., Choi, H.-S., Dolan, B. M., Choi, S.-Y., Chattarji, S., & Tonegawa, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705003104 · Cited by 281 · cited 6×
“S7; Supplemental Table S4; cf. Hayashi et al. 2007).”
BackgroundInfluentialSensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
Frankland, P. W., Wang, Y., Rosner, B., Shimizu, T., Balleine, B. W., Dykens, E. M., Ornitz, E. M., & Silva, A. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001432 · Cited by 275 · cited 2×
“We then studied whether 5HT compounds enhance GluA1-dependent synaptic plasticity in Fmr1 knockout mice, since all 5HT2-Rs, including 5HT2A-Rs, 5HT2B-Rs, and 5HT2C-Rs, can regulate synaptic plasticity (Jacobs and Azmitia 1992; Gaspar et al. 2003; Zhong et al. 2008).”
BackgroundMeredith, R. M., Holmgren, C. D., Weidum, M., Burnashev, N., & Mansvelder, H. D. (2007) · Neuron · doi:10.1016/j.neuron.2007.04.028 · Cited by 190 · cited 1×
“In addition, NMDA-R-dependent longterm potentiation (LTP) is significantly reduced in Fmr1 knockout mice (Zhao et al. 2005; Meredith et al. 2007; Hu et al. 2008; Shang et al. 2009; Seese et al. 2012) due to a selective impairment of signal transduction between Ras and PI3K/PKB that impairs…”
BackgroundFMRP Acts as a Key Messenger for Dopamine Modulation in the Forebrain
Wang, H., Wu, L.-J., Kim, S. S., Lee, F. J. S., Gong, B., Toyoda, H., Ren, M., Shang, Y.-Z., Xu, H., Liu, F., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.027 · Cited by 186
Fmr1 knockout mouse has a distinctive strain-specific learning impairment
Dobkin, C., Rabe, A., Dumas, R., El Idrissi, A., Haubenstock, H., & Ted Brown, W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00292-x · Cited by 179
Shang, Y., Wang, H., Mercaldo, V., Li, X., Chen, T., & Zhuo, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06314.x · Cited by 72 · cited 2×
“…NMDA-R-dependent longterm potentiation (LTP) is significantly reduced in Fmr1 knockout mice (Zhao et al. 2005; Meredith et al. 2007; Hu et al. 2008; Shang et al. 2009; Seese et al. 2012) due to a selective impairment of signal transduction between Ras and PI3K/PKB that impairs GluA1-dependent (but…”
BackgroundLee, S.-H., Lim, C.-S., Park, H., Lee, J.-A., Han, J.-H., Kim, H., Cheang, Y.-H., Lee, S.-H., Lee, Y.-S., Ko, H.-G., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.041 · Cited by 58 · cited 1×
“Biochemical analysis followed our previous studies (Qin et al. 2005; Lee et al. 2007; Hu et al. 2008).”
Self-citation
Cited by
Advancing the understanding of autism disease mechanisms through genetics
de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827
Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders
Lee, E., Lee, J., & Kim, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.011 · Cited by 468
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
The Brain-Enriched MicroRNA miR-9-3p Regulates Synaptic Plasticity and Memory
Sim, S.-E., Lim, C.-S., Kim, J.-I., Seo, D., Chun, H., Yu, N.-K., Lee, J., Kang, S. J., Ko, H.-G., Choi, J.-H., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0630-16.2016 · Cited by 116
Self-citationTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
Metadata
- Authors
- Lim, C.-S., Hoang, E. T., Viar, K. E., Stornetta, R. L., Scott, M. M., & Zhu, J. J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-02-01
- Volume
- 28
- Issue
- 3
- Pages
- 273-289
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2119262860
- Cited by
- 56
- References
- 31
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.